![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, August 09, 2021 10:09:36 PM
1. US government funding through the DoD or DARPA. Sorrento already has growing connections with these sources.
2. Poster Sal suggested a Mexican government route.
a. Mexican president rails against big pharma, vaccines, and access...
b. Sorrento creates a fully owned subsidiary in Mexico: Sorrento Therapeutics Mexico (“Sorrento Mexico”) and INMEGEN have executed an MOU to further collaborate on clinical development of a broad pipeline of COVID products, including "diagnostics, MULTIVALENT mRNA-based VACCINES and therapeutics". Sorrento provides its most comprehensive portfolios and a “one-stop-shop" of potential solutions for governments interested in a multi-modal “detect and treat” approach to the COVID-19 pandemic.
c. Sorrento gets a Mexican Warp Speed grant from Mexico.
3. Sorrento said back on June 2,2021 that it "..is seeking major global partnership(s) to co-develop and co-commercialize Abivertinib." Abivertinib has many applications to cancers, autoimmune diseases and Covid anti-cytokine storm. Wouldn't any large pharma interested in a global partnership for Abivertinib also be interested in a second generation mRNA Covid vaccine? It is very possible. Clearly Sorrento has been working on the mRNA vaccine for at least 6 months. And global partnerships have been on the table for over 2 months.
These are 3 plausible routes. We may soon learn which path Sorrento has chosen!
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM